Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
60%(3 trials)

Phase Distribution

Ph phase_4
1
20%
Ph phase_3
1
20%
Ph not_applicable
1
20%
Ph early_phase_1
1
20%
Ph phase_1
1
20%

Phase Distribution

2

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
1(20.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(5)

Detailed Status

Completed5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (20.0%)
Phase 11 (20.0%)
Phase 31 (20.0%)
Phase 41 (20.0%)
N/A1 (20.0%)

Trials by Status

completed5100%

Recent Activity

0 active trials
Showing 5 of 5
completedphase_1

A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and Abdomen

NCT04893798
completedphase_3

Sayana® Press Extension Study

NCT03154125
completedearly_phase_1

Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers

NCT03255941
completedphase_4

Sayana Press UK Self-Injection Study

NCT03034057
completednot_applicable

Sayana® Press Self-injection Study in Malawi

NCT02293694

Clinical Trials (5)

Showing 5 of 5 trials
NCT04893798Phase 1

A Study Comparing Subcutaneous Injection of Sayana Press In the Upper Arm Versus Anterior Thigh and Abdomen

Completed
NCT03154125Phase 3

Sayana® Press Extension Study

Completed
NCT03255941Early Phase 1

Clinical Study of Depo Provera Comparing Lay Health Workers and Clinically-trained Health Workers

Completed
NCT03034057Phase 4

Sayana Press UK Self-Injection Study

Completed
NCT02293694Not Applicable

Sayana® Press Self-injection Study in Malawi

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5